KESKO B/ FI0009000202 /
31/05/2024 08:15:37 | Var. +0.010 | Volume | Denaro13:43:54 | Lettera13:43:54 | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
16.700EUR | +0.06% | 0 Fatturato: 0.000 |
16.700Quantità in denaro: 306 | 16.740Quantità in lettera: 305 | 6.7 bill.EUR | 6.10% | 13.37 |
GlobeNewswire
14:00
Haoxi Health Technology Limited Reports Unaudited Financial Results for The Six Months Ended Decembe...
GlobeNewswire
14:00
Generation Lab Introduces First Platform that Measures Aging & Treatment Efficacy to Help Extend the...
GlobeNewswire
14:00
Autolus Therapeutics presents longer-term follow-up and additional data analysis of Pivotal Phase 2 ...
GlobeNewswire
14:00
Lipella Pharmaceuticals Announces Completion of Site Initiation Visit for Phase 2a Trial of LP-310 i...
GlobeNewswire
14:00
Milestone® Pharmaceuticals to Participate in the Upcoming Jefferies Global Healthcare Conference
GlobeNewswire
14:00
Aptose Announces $4.43 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
GlobeNewswire
14:00
PodcastOne (Nasdaq: PODC) Appoints Wall Street Veteran Jon Merriman to Its Board of Directors
GlobeNewswire
14:00
ABM Named Among Barron’s 100 Most Sustainable Companies for Second Consecutive Year
GlobeNewswire
14:00
Iterum Therapeutics Receives FDA Acceptance of Resubmission of NDA for Oral Sulopenem for the treatm...
GlobeNewswire
14:00
SOND INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sonder Holdings Inc. Investors...
GlobeNewswire
13:30
Adaptive Biotechnologies Announces Data Supporting the Clinical Benefits of MRD Assessment with clon...
Newsfile Corp
13:30
Tronic Metals to Participate in THE Mining Investment Event of the North, Canada's Only Tier I Globa...